• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·DABUR.NS
Share

Dabur India Limited Stocks

₹ 376.8Last Updated 08.10.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

₹ 6.89B

₹ 376.8
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dabur India Limited functions as a leading global fast-moving consumer goods (FMCG) enterprise, conducting its operations through distinct Consumer Care Business, Foods Business, Retail Business, and Other segments. Its comprehensive product portfolio encompasses a diverse array of health supplements, such as Dabur Chyawanprash, Dabur Vita, Dabur Honey, Dabur Immunity Kit, Dabur Vedic Suraksha Tea, and Dabur Glucose. The company also offers digestive aids including Dabur Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol. In the realm of personal care, Dabur provides shampoos like Dabur Almond and Vatika, alongside hair oils marketed under the Dabur Amla, Vatika, Dabur Almond, and Anmol brands. Its skincare collection features Dabur Gulabari, Oxylife, and Dabur Fem, while its oral hygiene solutions include Dabur Red Paste, Dabur Meswak, Dabur Babool, Dabur Lal Dant Manjan, Dabur Red Pulling Oil, and Dabur Dant Rakshak Ayurvedic Paste. The company’s food and beverage division supplies fruit juices (Real, Real Activ), cooking pastes (Hommade), and milk-based beverages (Real Milk Power). Furthermore, Dabur's health and wellness offerings extend to energizers and rejuvenators such as Shilajit, Shilajit Gold, Shilajit Double Gold, and Dabur Musli Gold. It addresses cough and cold symptoms with Dabur Honitus and Dabur Tulsi Drops, produces various health juices, and offers women's health products like Dabur Dashmularishta and Dabur Ashokarishta. An Ayurvedic baby massage oil, Dabur Lal Tail, and other ethical Ayurvedic products are also part of its range. Beyond health and personal care, Dabur provides household essentials, including Odomos mosquito repellent, Odonil air freshener, Sanifresh Shine toilet cleaner, Odopic dish wash, and DABISCO natural gum products. Additionally, Dabur operates specialized beauty retail stores under the NewU brand, which feature a curated selection of cosmetics, fragrances, skincare, personal care items, and fashion accessories. Dabur India Limited was established in 1884 and maintains its headquarters in Ghaziabad, India.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of DABUR.NS is 489 and suggests 29.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

10.10.2026 04:25

Apple has cut orders for parts for the new iPhones, according to media reports. Was demand lower than expected?

10.10.2026 03:01

An analyst sees Starlink's transition into a cell phone carrier as a problem for Apple and Samsung

10.10.2026 02:09

Iran threatens to target ships beyond Hormuz as oil exports out of Persian Gulf rise

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026